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Abstract
Purpose: To assess magnetic resonance imaging (MRI) features of rectal carcinoma in correlation with pathology,  
and to evaluate the diagnostic accuracy of 3-Tesla MRI.
Material and methods: A total of 86 patients were included. 3T MR imaging was conducted pre-operatively, with im-
aging data correlated to pathology results. High-resolution, 2-dimensional, T2-weighted fast-spin echo sequences 
in the sagittal, axial, and coronal planes used to tumour staging. Diffusion-weighted images were used to increase 
the accuracy of tumour evaluation.
Results: Rectal carcinoma was staged as T3 in 45.3% of all patients (n = 39), without involvement of the mesorectal fas-
cia in 31.4% (n = 27), and with a possible or obvious invasion in 14% of patients (n = 12). The diagnostic accuracy of 
3T MRI was 97.6% for the T1 stage, 92.1% for T2, 89% for T3, and 90% for T4 tumours. MR-derived extramural vas-
cular invasion (EMVI) was found in 16.2% (n = 14), with an estimated diagnostic accuracy of 95%. Diffusion-weight-
ed images and apparent diffusion coefficient were estimated for the different histology types of rectal carcinoma.  
The average apparent diffusion coefficient for adenocarcinoma was 0.846 ± 0.17, for mucinous adenocarcinoma it 
was 1.17 ± 0.08, and for signet cell and squamous carcinomas it was 0.91 ± 0.11 and 0.796 ± 0.21 mm2/s, respectively.
Conclusions: 3T MRI enables high levels of diagnostic accuracy in local rectal carcinoma staging, including assessment 
of mesorectal fascia infiltration and EMVI-status with high accuracy.
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Introduction 
Colorectal carcinoma (CRC) is the fourth most frequently 
diagnosed malignancy, and the second leading cause of 
cancer-related deaths in developed countries. Rectal and 
sigmoid cancers account for up to 60% of all CRC cases [1]. 
Rectal carcinoma (RC) is the 8th most common cancer in 
Kazakhstan (4.5% or 8.2 cases/100,000 population) and 
the 8th leading cause of cancer-related mortality (4.7%). 
Wherein, despite slight growth in CRC incidence by 0.5% 
during the 2015-2018 period, mortality rates decreased 
by 9.6% [2]. 
According to the National Comprehensive Cancer 
Network, the incidence of CRC per 100,000 population 
decreased from 60.5 in 1976 to 46.4 in 2005 and kept de-
creasing at a rate of 2.9% annually from 2005 to 2014 [3]. 
These improvements in incidence and mortality from 
CRC are believed to be a result of early diagnoses through 
population screening and implementing novel treatment 
modalities. At the same time, the incidence of CRC in pa-
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tients younger than 50 years has been increasing. Similar-
ly, incidence rates for CRC among the young population 
are expected to increase by 90.0-124.2% by 2030 [1,3]. 
The role of imaging in CRC management has evolved 
greatly. Assessing the depth of tumour invasion, lymph 
node involvement and distant metastases determines the 
treatment option and overall prognosis. As of now, there is 
no consensus on preferred imaging modality for the final 
staging of RC is often a result of a complex approach with 
several imaging tools [4-6]. 
High-resolution magnetic resonance imaging (MRI) 
allows an excellent soft tissue contrast resolution, func-
tional imaging ability, and multiplanar acquisition, as-
suring thorough RC evaluation [5-7]. Due to its ability to 
accurately evaluate the mesorectal fascia, anal sphincter, 
as well as mesorectal and pelvic lymph nodes, MRI has 
become a tool of choice for RC staging [8-10]. 
The purposes of this study are (i) depicting 3-Tesla (3T) 
MRI features of RC in correlation with histopathology re-
sults and (ii) assessment of its diagnostic accuracy for ex-
tramural tumour spread and involvement of lymph nodes. 
Material and methods
Patients 
This retrospective study was conducted at a leading in-
country cancer care institution and included all 86 pa-
tients (46 men and 40 women, mean age 61.7 ± 12.9 years) 
with a newly diagnosed RC between January 2015 and 
June 2018. The study was approved by the institutional 
review board. The inclusion criterion was a new diagnosis 
of pathology-proven RC with no gender or age predilec-
tion. Patients who did not undergo the surgery and/or did 
not complete path evaluation, or did not obtain optimal 
imaging were excluded from the study. 
Magnetic resonance scan protocol
Pre-operative MR imaging was performed on a 3T MR 
system (GE Discovery MR750w, USA), utilizing a pelvic 
phased-array surface coil (Gem body coil 8 ch.). The se-
quences and related parameters are listed in Table 1. 
High-resolution, 2-dimensional, T2-weighted, fast spin-
echo (FSE) sequences in sagittal, axial, and coronal planes 
were used to create an imaging basis for the MR staging. 
The scanning started with the sagittal series, to plan the 
axial images, perpendicular to the rectal wall at the level of 
the tumour (to avoid volume averaging). Coronal images 
were oriented parallel to the anal canal for low rectal tu-
mours to estimate the sphincter involvement, but parallel to 
the rectal wall in all other cases. Diffusion-weighted images 
were used to improve the imaging accuracy of tumour and 
lymph node involvement. T1-weighted images were used to 
assess concomitant changes and pelvic bones. MR examina-
tions were performed without gadolinium administration.
Image analysis
The tumour was considered either as polypoid, an endo-
phytic ulcerous, an exophytic circular, or as diffuse in-
filtrative type, based on the gross morphology. We have 
evaluated the tumour extension in centimetres (cm) and 
the tumour level – the distance from anorectal transition 
to the lower border of the tumour – also in centimetres. 
Based on the latter, the level was considered as a lower, 
mid, or upper rectal tumour when the distance between 
lowest border of tumour and the anorectal junction is at 
0-5 cm, 5-10 cm, or 10-15 cm, respectively. 
The involvement of the circular resection margin is defined 
by measuring the distance from the border of the tumour or 
metastatic lymph nodes to the mesorectal fascia (MRF). The 
MRF was regarded as intact if the distance from the tumour 
margin was more than 2 mm; a possible invasion was consid-
ered when the distance was 1-2 mm, and MSF was evaluated 
as positive at a distance less than 1 mm [11-14].
According to the TNM 7th edition, lymph nodes (LN) are 
thought to be involved if greater than 5 mm in short axis, with 
other signs of malignancy including the heterogeneity, abnor-
mal shape, and ill-defined or radiant contours [15-17]. The 
disease was considered N0 if no suspicious LN was found, N1 
with 1-3 positive LN, or N2 when 4 or more LN were involved. 
Table 1. Magnetic resonance imaging sequences applied (3Т) for preoperative rectal carcinoma staging
Sequences T2 FSE-weighted imaging DWI T1 FSE axial
Sagittal Axial Coronal
TR (ms) 7300 5500 8700 6000 650
TE (ms) 90 120 100 90 9.4
Bandwidth (kHz) 83.3 41.7 41,7 250 50
FOV (mm) 260 260 260 260 260
Slice thickness (mm) 4 4 4 4 4
Spacing (mm) 0 0 0 0 0
Matrix 320 × 320 320 × 320 320 × 320 128 × 128 320 × 320
Acquisition time (min) 2 : 45 2 : 35 2 : 15 4 : 36 2 : 12
FSE – fast spin echo, DWI – diffusion-weighted imaging (b values were used: 0, 1000, 2000), FOV – field of view
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The following groups of LN were assessed: within the 
mesorectum, extra-mesorectal locoregional lymph nodes 
(perirectal, sigmoid mesenteric, inferior mesenteric, lateral 
sacral, presacral, internal iliac, sacral promontory, internal 
iliac, superior, middle, or inferior rectal (hemorrhoidal). 
The involvement of other groups of pelvic LN and inguinal 
LN are regarded as distant metastases. 
Extramural vascular invasion (EMVI) was assessed as 
the part of standard MR protocol [18-21]. 
Tumour morphology and staging
MRI reporting criteria for T and N staging of RC were listed 
as standard and described elsewhere [12-14]. Briefly, the tu-
mour confined only to submucosa is considered as T1, with 
involvement of the muscular layer but sparing perirectal fat 
as T2, with mesorectal fat invasion as T3, and the exten-
sion to other pelvic organs or peritoneum as T4. Diffusion 
restriction  (b = 1000) expressed by the apparent diffusion 
coefficient (ADC) was evaluated separately for adenocarci-
noma, mucinous carcinoma, squamous cell carcinoma, and 
signet cell RC. 
Histopathological evaluation
All patients underwent surgery. In all 86 patients, histo-
logical examination and pathological staging were per-
formed on the surgical specimens. Seventy-one out of 
a total of 86 patients underwent preoperative neoadjuvant 
therapy consisting of radiotherapy and\or chemotherapy. 
For this group of cases MRI was performed before and 
after neoadjuvant treatment, but for pathology-radiology 
correlation post-treatment MRI data was used. Pathologi-
cal staging was carried out according to TNM criteria [3]. 
A pathologist with 20 years of experience examined the 
specimens, blinded to the preoperative MR staging.
Statistical analysis
Correlative analysis of MRI and histopathological data 
was performed. The sensitivity, specificity, positive and 
negative predictive values, and accuracy of MRI for T and 
N stages of RC were calculated with 95% confidence in-
tervals (95% CIs). The MRI was assessed by 2 radiologists 
with 7 and 15 years of experience in oncology imaging, 
respectively. Interobserver agreement was assessed using 
Cohen’s κ coefficient. 
Results 
Tumour spread patterns
Exophytic character of tumour growth was found in 
63.95% (n = 55) of cases, diffuse-infiltrative semi-circular 
growth in 18.6% (n = 16), polypoid growth with/without 
a fibromuscular pedicle in 11.6% (n = 10), and endophytic- 
ulcerous growth in 5.8% (n = 5) of all samples. 
The low rectum was the most prevalent site of cancer 
among all RC cases (n = 46, 53.5%). The tumour was re-
stricted within the lower rectum in 19 (22.1%) cases, or 
in various combinations with the involvement of the anal 
canal and/or spread to the middle rectum (n = 27, 31.4%). 
The middle rectum was affected in 34 (39.5%) patients, 
while only in 10 (11.6%) cases the tumour was restricted 
by the mid rectum. In the rest of the cases, the tumour 
invaded the adjacent parts of upper or lower rectum. 
The upper rectum on the whole was affected in 22 (25.6%) 
cases, with the tumour affecting only the upper part of the 
rectum in 12 (13.9%) patients. An advanced process of RC 
affecting all parts of the rectum was observed in 7 cases 
(8.1%). The mean length of the lesions was 5.7 ± 2.4 cm 
(range 2.2 cm to 15.6 cm). 
EMVI was identified in 14 (16.2%) of all RC cases 
(Figure 1). The estimated diagnostic accuracy of MRI for 
EMVI as compared with tumour endovascular emboli 
evidence on pathology was 95%.
Correlation of rectal carcinoma imaging characteristics 
and histological profile
The distribution of included RC cases by histological 
groups is presented in Table 2. The majority of RC cases 
Figure 1. Extramural vascular invasion in G2 (A) and G3 (B) rectal carcinomas (arrows)
A B
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was a moderately differentiated (G2) adenocarcinoma 
(n = 51, 59.3%), and the rarest type was signet ring cell 
carcinoma (n = 4, 4.65%). However, the signet ring cell 
carcinoma had greater tumour sizes (8.1 ± 1.6 cm) in 
comparison with other RC histological types. 
Mucinous adenocarcinoma was histologically verified 
in 13 (15.1%) cases. Eight out of 13 patients with histologi-
cally proven mucinous adenocarcinoma cases were staged 
as T3 (61.5%), 4 of them as T4 (30.8%), and only 1 as T2 
(7.7%) at the moment of diagnosis. A significant differ-
ence in ADC was obtained for mucinous adenocarcinoma 
(1.17 ± 0.08 × 10-3 mm2/s) when the ADC was less than 
0.9 × 10-3 mm2/s for all other histological groups (p ≤ 0.05). 
Magnetic resonance staging in comparison  
with histopathological data
The results of pre- and postoperative T and N staging of 
are presented in Tables 3 and 4.
The discrepancy between the MR and pathological 
T staging was noted in 16 cases out of 86. Pathomorpholo-
gical examination found 1 case of Tis stage (villus adenoma 
with intramucosal foci of adenocarcinoma), while on MRI 
the lesion was described as a T2 rectal polypoid lesion. In 
5 cases, MRI overestimated the involvement of adjacent 
pelvic organs with fibrosis after neoadjuvant therapy, but 
pathomorphology excluded the invasion of adjacent or-
gans (T4 stage lowered to T3). In 2 cases we evaluated 
lesions as T1 stage on MRI data, while pathomorphol-
ogy revealed the focus of invasion in the muscle layer, so 
T2 stage has been verified. In 3 cases the T2 stage of MRI 
was verified as pT3a during pathological examination. 
In 4 RC cases the cT3 stage by MRI was changed as pT4 
after pathomorphological study (in patients after neoadju-
vant chemoradiation therapy).
The discrepancy between radiological study and his-
topathology for N staging was found in 10 cases out of 
86. The agreement was defined as substantial (0.78) for 
T staging, moderate (0.57) for N staging, and substantial 
for extramural vascular invasion assessment (0.63). 






Signet ring cell 
carcinomaG1 G2 G3
N = 86 (100%) 3 (3.5%) 51 (59.3%) 7 (8.1%) 13 (15.1%) 8 (9.3%) 4 (4.65%)
ADC b = 1000 (*10-3 mm2\s) 0.846 ± 0.17 1.17 ± 0.08 0.91 ± 0.11 0.79 ± 0.21 – –
Tumour size (cm) 3.9 ± 1.9 5.7 ± 2.5 6.7 ± 1.4 7.2 ± 2.7 4.26 ± 1.7 8.1 ± 1.6
Table 3. T-staging: comparison of magnetic resonance imaging data and 
histopathological examination
Path MRI Total 
pathТis Т1 Т2 Т3 Т4 FN
Tis – – 1 – – 1 1
Т1 – 3 – – – – 3
Т2 – 2 13 1 – 3 16
Т3 – – 3 34 5 8 42
Т4 – – – 4 20 4 24
FP – 2 4 5 5 16
TN 81 69 47 61 –
Total – 5 17 39 25 – 86
Path – pathomorphological data: TN – true negative, FN – false negative, FP – false positive
Table 4. N-staging: comparison of magnetic resonance imaging data and 
histopathological examination
Path MRI Total 
pathN0 N1-2-3 FN
N0 10 6 6 16
N1-2-3 4 66 4 70
FP 4 6 10 –
TN 64 12 – –
Total 14 72 – 86
Path – pathomorphological data, TN – true negative, FN – false negative, FP – false-positive
Table 5. Diagnostic value 3T magnetic resonance imaging in T staging of rectal carcinoma
Stage Sensitivity Specificity Positive predictive value Negative predictive value Accuracy
Т1 100% 97.5% 100% 71.9% 97.6%
Т2 81.3% 94.5% 95.3% 78.5% 92.1%
Т3 87.1% 92.1% 85.1% 87.5% 89.0%
Т4 83.3% 92.4% 93.1% 81.9% 90.0%
Average 87.9% 94.1% 93.4% 80.0% 92.2%
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The diagnostic accuracy of 3T MRI for different 
T and N stages of RC obtained in our work is presented in 
Tables 5 and 6. The sensitivity and specificity of 3T MRI 
for the T1 stage was 100% and 97.5%, respectively, for T2 
it was 81.3% and 94.5%, respectively, and for T3 stage it 
was 87.1% and 92.1%, respectively. 
T1 stage of RC without involvement of the muscular 
layer of the rectal wall was recorded in 5 patients (5.8%) ac-
cording to MR data, while T2 stage with involvement of the 
muscular layer was recorded in 17 patients (19.8%). Most 
of the primary RC cases were staged as T3 – in 39 (45.3%) 
patients, including 27 (31.4%) cases without involvement of 
the mesorectal fascia (MRF–), and with a possible or obvi-
ous invasion (MRF+) in 12 (14%) cases. Locally advanced 
tumour involving either pelvic peritoneum (T4a) or pelvic 
organs (T4c) was noted in 25 (29.1%) cases. In the evalua-
tion of metastatic lymph nodes, we obtained a total sensi-
tivity of 83.4% and a specificity of 80.4%. 
Discussion 
Our data revealed several patterns of tumour growth. More 
than a half of the RC cases had exophytic character of 
growth. In previously published data, exophytic growth pat-
tern varied between 13.5 and 50% for different CRC stages 
[35]. The lower third of the rectum was the part most com-
monly affected by RC in our study (53.5%). According to 
the published data, the frequency of primary involvement 
of particular parts of the rectum varies, but it most often 
seen in the upper and middle third of the rectum [13,14]. 
Similarly, Brown et al. in 2006 reported the upper third vs. 
middle third rectal lesion in 34% and 36% of patients, re-
spectively, while the lower lesion was seen only in 20% [6]. 
However, more often we observed an advanced process 
involving 2 or more parts of the rectum, with the predomi-
nant location being within the lower rectum.
EMVI is a known risk factor for early recurrence, tu-
mour aggressiveness, and compromised sensitivity to neo-
adjuvant chemoradiotherapy [18,19]. It is also associated 
with poor prognosis of the course of disease and low over-
all survival [20-22]. The sensitivity and specificity of MRI 
in detection of EMVI were 62% and 88%, respectively, in 
the study of Smith et al. in a 94-patient cohort [18]. Thus, 
MR-EMVI is used as a potential biomarker that facilitates 
the choice of method of treatment [18,19]. Sohn et al. 
proposed the MRI-detected EMVI as an independent risk 
factor for distant metastases; therewith the involvement of 
the large vessels (more than 3 mm in diameter) is associ-
ated with a higher risk in comparison with small vessels 
measuring less than 3 mm [19]. Similarly, Barbaro et al. 
showed the relationship of EMVI and risk of synchronous 
metastases in patients with a non-mucinous adenocarci-
noma [21].  
Mucinous adenocarcinoma has higher stage at the time 
of initial diagnosis, worse prognosis, and lower sensitivity 
to chemotherapy [22,23]. The tumour is considered mu-
cinous if it contains at least 50% of the mucinous cells, 
wherein, mucinous components may be located in the 
submucosal or muscular layer and not be detected during 
colonoscopy [7,8]. Thus, the discovery of a mucus-forming 
tumour on MRI has clinical significance. In addition, some 
authors suggest a certain sampling error and underdiagno-
sis of mucinous component from histological biopsy given 
the heterogeneity of mixed forms of the lesions, which em-
phasizes the role of MRI in the differentiation of mucinous 
and non-mucinous forms of RC [7]. Attempts to differenti-
ate mucinous from non-mucinous entities were proposed 
on the basis of increased T2 signal of rectal tumour as well 
Table 6. Diagnostic value 3T magnetic resonance imaging in N staging of rectal carcinoma
Stage Sensitivity Specificity Positive predictive value Negative predictive value Accuracy
N0 72.5% 94.1% 70.8% 91.7% 88.2%
N 1, 2, 3 94.3% 66.7% 92.5% 72.7% 89.2%
Average 83.4% 80.4% 81.7% 82.2% 88.7%
Figure 2. Rectal well-differentiated mucinous adenocarcinoma G1. High signal intensity of circular rectal tumour (arrows) with invasion of all layers of the rectal 
wall in T2 FSE sagittal (A) and axial (B) images. DWI with b = 1000 (C) shows restricted diffusion within the tumour tissue (arrow), ADC = 1.7 mm2\s × 10-3
A B C
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as on the ADC value on DWI (Figure 2). It was shown that 
the diffusion coefficient is the most reliable factor for dif-
ferentiation, whereas the sensitivity and specificity of T2 
images are much lower [23].
However, according to the published data, there is 
still no consensus on the role of DWI. For example, in-
flammation within the submucosal layer of the rectal wall 
can lead to restricted diffusion and false positive results 
of DWI MRI [23-25]. There are studies supporting the 
use of diffusion-weighted mode to improve the diagnostic 
capabilities in assessing the local prevalence of rectal can-
cer and its recurrence. Thus, according to Balyasnikova 
et al., the use of DWI allows MRI specificity to be slightly 
increased, especially in patients receiving neoadjuvant 
therapy [8]. Barbaro et al. also reported significant dif-
ferences in ADC values for mucinous and non-mucinous 
forms of rectal adenocarcinoma, and according to the 
positron emission tomography data from the same study, 
no significant differences of FDG uptake were obtained 
for these histological forms [22]. Çolakoğlu et al. reported 
statistically significant differences in the ADC for muci-
nous and non-mucosal adenocarcinoma [23]. There are 
also data showing that the direct estimation of DWI with 
calculation of ADC allows, with more than 90% specific-
ity, prediction of the tumour response to radiation and 
chemotherapy [22,23]. However, according to Lambregts 
et al., DWI, including DWI-fused images, generally does 
not improve sensitivity and specificity of MR in mucinous 
RC staging [26]. A number of publications define ADC as 
a potential predictive biomarker that can assess the ag-
gressiveness of a tumour [26-28]. 
The intensity of MR signals of the lesions at T2 FSE 
varied from homogeneous iso-intensive to hyperintense 
inhomogeneous. Diffuse or heterogeneous amplification 
of the MR signal on T2 images was considered for muci-
nous tumours [22,23].
In similar research, the T3 stage was the dominant 
group in the studied cohort of patients (45-80%) [29,30]. 
Thus, in the large multicentre MERCURY study [6], 
T3-stage was 45%, T2 – 18%, T1 – 8%, and T4 – 6%. In the 
studies of Sani et al. and Chatterjee et al. [13,14] the portion 
of T3 patients was 67% and 80%, respectively. In the data 
of similar research, the distribution of patients within the 
groups according to such important criteria as involvement 
of mesorectal fascia (T3) or differences in the involvement 
of only the pelvic peritoneum or pelvic organs (T4 stage) is 
not given. At the same time, T4 stage was usually associated 
with involvement of pelvic organs; isolated lesion of pelvic 
peritoneum was much less common.
Pathomorphological examination found 1 case of Tis 
stage in our study. This case can be considered as casu-
istry, rarely observed in everyday practice; the recognition 
of the Tis stage lies outside the diagnostic capabilities of 
MRI. In this turn, when visualizing polypoid lesion, it is 
difficult to judge about the benign or malignant nature of 
the tumour based only on MR data. 
In 5 cases, the involvement of adjacent pelvic organs 
after neoadjuvant therapy was overestimated and T4 stage 
was considered. This problem is often mentioned in simi-
lar previous studies [14,29,30]. Post-radiation fibrosis, as 
a rule, is usually present in patients with RC cases, which 
makes it difficult to determine the exact boundaries of the 
primary tumour and pre-operative re-staging. A possible 
solution to this problem is the use of DWI with a suffi-
ciently high b-factor [24,33], and application of additional 
postcontrast series [11,12], as well as the use of thin-cut-
ting (1-2 mm) 3-dimensional T2 series [29,33].
Difficulties in recognizing the T1-T2 stage are often 
mentioned in the literature, especially in early studies 
based on 1.5T MRI [8-10]. Although many researchers 
did not notice significant differences in the sensitivity and 
specificity of 1.5T and 3T MRI in RC staging, 3T MRI 
provides a higher sensitivity in differentiation of the sub-
mucosal layer and the muscular wall [8,29,30]. 
Mistakes in differentiation of T2 and T3a stages of RC 
(limited spread beyond the limits of muscularis propria 
plate to mesorectal fat) due to desmoplastic reaction and 
postradiation fibrosis are also often mentioned as one of 
the main reasons for decreased sensitivity and specificity 
of MRI [10-14,29,33]. In this case, the sensitivity for the 
T3 stage in these sources varied from 71 to 83%, and the 
specificity from 20 to 76%. Despite generally recognized 
limitations of MRI in separation of T2 and T3a, a clinical 
significance of this fact is small because the same therapeu-
tic approach is used for these patients in many countries. 
The detection of metastatic LN on MRI remains a dif-
ficult issue because of the multifactorial determinants of 
the involved nodes (size, margins, internal structure, and 
restriction of diffusion) [10,16]. On top of that, it is gener-
ally accepted that metastatic LNs in RC are usually small 
(0.3-0.5 cm) and it is hard to detect MR criteria of meta-
static lesions [15-17]. Help in the differentiation of meta-
static LNs is provided by the DWI technique, which is rec-
ommended by many authors [24,27,31,32]. However, the 
data on sensitivity and specificity of MRI for N-staging 
remain heterogeneous. Thus, in the study of Chatterjee 
et al. the sensitivity of MRI for N-criterion was 100% and 
the specificity was 78%. 
Wherein, a relatively low sensitivity of MRI for N0 stage 
was noticed – 72%, with a sufficiently high specificity of 
94%, which indicates a potential overdiagnosis of meta-
static LNs on MRI. Conversely, in the presence of meta-
static nodes (N1-2), the pattern of the reliability of results 
is reversed – high sensitivity of 94% and low specificity of 
66%. Winter et al. reported about 95% and 91% accuracy 
of MR in T and N staging, respectively [30]. Kim et al. 
showed similar results in a group of 42 patients, where the 
diagnostic accuracy for N stage was 84-90% [33].
One of the important limitations of our study is the large 
variation of numbers of different T stages – a small num-
ber of Tis and T1 lesions but a large share of included T3 
samples. Another limitation is that we did not divide the in-
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cluded RC cases to primary MR staging and MR staging after 
neoadjuvant treatment groups, and we did not analyse the 
diagnostic accuracy of 3T MRI for these groups separately. 
Conclusions
Using a sufficiently large pool of cases, we assessed the 
dia gnostic value of 3T MRI for both T and N staging, and 
we achieved fair accuracy of the results. According to our 
study, the diagnostic accuracy of 3T MRI is 92.2% for the 
T staging and 88.7% for the N staging. The role of DWI in 
the pre-operative estimation of primary rectal tumour was 
proven to be significant, which allows the determination of 
a group of patients with high risk, and with more aggressive 
histology subtypes. Overall, 3T MRI using surface coils al-
lows an accurate non-invasive diagnostic determination of 
rectal carcinoma.
Conflict of interest
The authors report no conflict of interest.
References
1. Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends 
in colorectal cancer incidence and mortality. Gut 2017; 66: 683-691. 
2. Oncology service statistics review (statistic data of Kazakh State In-
stitution of Oncology and Radiology)/under rev. of Prof. Kaidarova 
DR, Almaty; 2018. 
3. Cheng L, Eng C, Nieman LZ, et al. Trends in colorectal cancer inci-
dence by anatomic site and disease stage in the United States from 
1976 to 2005. Am J Clin Oncol 2011; 34: 573-580.
4. Benson AlB, Vernook AP. Rectal cancer, Version 2.2018. Clinical 
practice guidelines in oncology. J Natl Compr Canc Netw 2018; 16: 
874-901.
5. Hricak H, Husband J, Panicek DM. Oncologic Imaging: Essentials 
of Reporting Common Cancers. Translated under rev. of Tuyrin IE. 
М: Practical Medicine; 2014, p. 42-49.
6. Heo SH, Kim JW, Shin SS, et al. Multimodal imaging evaluation in 
staging of rectal cancer. World J Gastroenterol 2014; 20: 4244-4255.
7. MERCURY Study Group. Diagnostic accuracy of preoperative mag-
netic resonance imaging in predicting curative resection of rectal 
cancer: prospective observational study. BMJ 2006; 333: 779. 
8. MERCURY Study Group. Extramural depth of tumor invasion at 
thin-section MR in patients with rectal cancer: results of the MER-
CURY study. Radiology 2007; 243: 132-139. 
9. Balyasnikova SS, Suraeva YE, Dolgushin BI, et al. The role of mag-
netic resonance imaging in the assessment of the rectal carcinoma 
local spread. Coloproctology 2014; 1: 4-13.
10. Berezovskaya TP, Nevolskih AA, Berdov BA, Shavladze ZN. Diag-
nostic capabilities of the magnetic resonance imaging in rectal car-
cinoma. Coloproctology 2014; 1: 14-21.
11. Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to 
the interpretation of preoperative staging MRI for rectal cancer. AJR 
Am J Roentgenol 2008; 191: 1827-1835.
12. Tapan Ü, Özbayrak M, Tatlı S. MRI in local staging of rectal cancer: 
an update. Diagn Interv Radiol 2014; 20: 390-398.
13. Jhaveri KS, Hosseini-Nik H. MRI of rectal cancer: an overview 
and update on recent advances. AJR Am J Roentgenol 2015; 205: 
W42-W55.
14. Chatterjee P, Eapen A, Perakath B, Singh A. Radiologic and patho-
logical correlation of staging of rectal cancer with 3 Tesla magnetic 
resonance imaging. Can Assoc Radiol J 2011; 62: 215-222.
15. Sani F, Foresti M, Parmiggiani A, et al. 3-T with phased array surface 
coil in the local staging of rectal cancer. Radiol Med 2011; 116: 375-388.
16. Wang C, Zhou Z, Wang Z, et al. Patterns of neoplastic foci and lymph 
node micrometastasis within the mesorectum. Langenbecks Arch 
Surg 2005; 390: 312-318. 
17. Kim JH, Beets GL, Kim MJ, et al. High-resolution MR imaging for 
nodal staging in rectal cancer: are there any criteria in addition to the 
size? Eur J Radiol 2004; 52: 78-83.
18. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of 
lymph node status in rectal cancer with use of high-spatial-resolution 
MR imaging with histopathologic comparison. Radiology 2003; 227: 
371-377.
19. Smith NJ, Barbachano Y, Norman AR, et al. Prognostic significance of 
magnetic resonance imaging-detected extramural vascular invasion in 
rectal cancer. Br J Surg 2008; 95: 229-236.
20. Sun Y, Li J, Wang X, Tong T, Gu Y. Predictive value оf MRI-detected 
extramural invasion in stage N3 rectal cancer patients before neoaju-
vant chemoradiation. Diagn Interv Radiol 2018; 24: 128-134.
21. Tripathi P, Rao SX, Zeng MS. Clinical value of MRI-detected ex-
tramural venous invasion in rectal cancer. J Dig Dis 2017; 18: 2-12.
22. Sohn B, Lim JS, Kim H, et al. MRI-detected extramural vascular in-
vasion is an independent prognostic factor for synchronous metas-
tasis in patients with rectal cancer. Eur Radiol 2015; 25: 1347-1355.
23. Barbaro B, Leccisotti L, Vecchio FM, et al. The potential predictive 
value of MRI and PET-CT in mucinous and nonmucinous rectal can-
cer to identify patients at high risk of metastatic disease. Br J Radiol 
2017; 90: 20150836.
24. Çolakoğlu Er H, Erden A. Mean ADC values discriminate rectal mu-
cinous carcinoma from rectal nonmucinous adenocarcinoma. Turk 
J Med Sci 2017; 47: 1520-1525.
25. Bauerle T, Seyler L, Munter M, et al. Diffusion weighted imaging 
in rectal carcinoma patients without and after chemoradiotherapy: 
a comparative study with histology. Eur J Radiol 2013; 82: 444-452.
26. Monguzzi L, Ippolito D, Bernasconi DP, et al. Locally advanced rec-
tal cancer: value of ADC mapping in predict of tumor response to 
radiochemotherapy. Eur J Radiol 2013; 82: 234-240.
27. Lambregts D, Cappendijk V, Maas M, et al. Value of MRI and dif-
fusion-weighted MRI for the diagnosis of locally recurrent rectal 
cancer. Eur Radiol 2011; 21: 1250-1258. 
28. Curvo-Semedo L, Lambregts DM, Maas M, et al. Diffusion-weight-
ed MRI in rectal cancer: apparent diffusion coefficient as a potential 
noninvasive marker of tumor aggressiveness. J Magn Reson Imaging 
2012; 35: 1365-1371.
Jandos Amankulov, Galiya Akhmetova, Dias Toleshbaev, et al.  
e224 © Pol J Radiol 2021; 86: e217-e224
29. Hunter CJ, Garant A, Vuong T, et al. Adverse features on rectal MRI 
identify a high-risk group that may benefit from more intensive pre-
operative staging and treatment. Ann Surg Oncol 2012; 19: 1199-1205. 
30. Futterer JJ, Yakar D, Strijk SP, et al. Preoperative 3T MR imaging of 
rectal cancer: local staging accuracy using a two-dimensional and 
three-dimensional T2-weighted turbo spin echo sequence. Eur J Radiol 
 2008; 65: 66-71.
31. Winter L, Bruhn H, Langrehr J, et al. Magnetic resonance imaging in 
suspected rectal cancer: determining tumor localization, stage, and 
sphincter-saving resectability at 3-Tesla-sustained high resolution. 
Acta Radiol 2007; 48: 379-387.
32. Altman DG, Bland JM. Diagnostic tests 1: sensitivity and specificity. 
BMJ 1994; 308: 1552. 
33. Karmazanovskii GG. Estimation of the diagnostic method value 
(“sensitivity”, “specificity” and “general accuracy”). Ann Surg Hepa-
tol 1997; 2: 139-142.
34. Кim SH, Lee JM, Lee MW, et al. Diagnostic accuracy of 3.0-Tesla 
rectal magnetic resonance imaging in preoperative local staging of 
primary rectal cancer. Invest Radiol 2008; 43:587-593.
35. Papagiorgis PC, Zizi AE, Tseleni S, et al. Clinicopathological differ-
ences of colorectal cancers according to tumor origin: Identification 
of possibly de novo lesions. Biomed Rep 2013; 1: 97‐104. 
